{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:59:35Z","timestamp":1761929975730},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T00:00:00Z","timestamp":1550016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00432-019-02858-7","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T21:40:56Z","timestamp":1550007656000},"page":"1021-1026","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Does FDG PET\/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients?"],"prefix":"10.1007","volume":"145","author":[{"given":"Hye Lim","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ie Ryung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Ha","family":"Boo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonya Youngju","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Kil","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sook Whan","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Whan","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"2858_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s12149-018-1301-9","volume":"32","author":"H Anwar","year":"2018","unstructured":"Anwar H, Vogl TJ, Abougabal MA, Gr\u00fcnwald F, Kleine P, Elrefaie S, Nour-Eldin NA (2018) The value of different 18F-FDG PET\/CT baseline parameters in risk stratification of stage I surgical NSCLC patients. Ann Nucl Med 32:687\u2013694","journal-title":"Ann Nucl Med"},{"key":"2858_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/01.JTO.0000268669.64625.bb","volume":"2","author":"L Horn","year":"2007","unstructured":"Horn L, Sandler AB, Putnam JB Jr, Johnson DH (2007) The rationale for adjuvant chemotherapy in stage I non-small cell lung cancer. J Thorac Oncol 2:377\u2013383","journal-title":"J Thorac Oncol"},{"key":"2858_CR3","doi-asserted-by":"publisher","first-page":"e5935","DOI":"10.1097\/MD.0000000000005935","volume":"96","author":"E Jeong","year":"2017","unstructured":"Jeong E, Hyun SH, Moon SH, Cho YS, Kim BT, Lee KH (2017) Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection. Medicine (Baltimore) 96:e5935","journal-title":"Medicine (Baltimore)"},{"key":"2858_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2018.02.013","volume":"119","author":"YK Kang","year":"2018","unstructured":"Kang YK, Song YS, Cho S, Jheon S, Lee WW, Kim K, Kim SE (2018) Prognostic stratification model for patients with stage I non-small cell lung cancer adenocarcinoma treated with surgical resection without adjuvant therapies using metabolic features measured on F-18 FDG PET and postoperative pathologic factors. Lung Cancer 119:1\u20136","journal-title":"Lung Cancer"},{"key":"2858_CR5","doi-asserted-by":"publisher","first-page":"e434","DOI":"10.1097\/MD.0000000000000434","volume":"94","author":"KH Ko","year":"2015","unstructured":"Ko KH, Hsu HH, Huang TW, Gao HW, Cheng CY, Hsu YC, Chang WC, Chu CM, Chen JH, Lee SC (2015) Predictive value of 18F-FDG PET and CT morphologic features for recurrence in pathological stage IA non-small cell lung cancer. Medicine (Baltimore) 94:e434","journal-title":"Medicine (Baltimore)"},{"key":"2858_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/RLU.0000000000000740","volume":"40","author":"E Kurtipek","year":"2015","unstructured":"Kurtipek E, Cayci M, D\u00fczg\u00fcn N, Esme H, Terzi Y, Bakdik S, Ayg\u00fcn MS, Unl\u00fc Y, Burnik C, Bekci TT (2015) (18)F-FDG PET\/CT mean SUV and metabolic tumor volume for mean survival time in non-small cell lung cancer. Clin Nucl Med 40:459\u2013463","journal-title":"Clin Nucl Med"},{"key":"2858_CR7","doi-asserted-by":"publisher","first-page":"e0146195","DOI":"10.1371\/journal.pone.0146195","volume":"11","author":"J Liu","year":"2016","unstructured":"Liu J, Dong M, Sun X, Li W, Xing L, Yu J (2016) Prognostic value of 18F-FDG PET\/CT in surgical non-small cell lung cancer: a meta-analysis. PLoS One 11:e0146195","journal-title":"PLoS One"},{"key":"2858_CR8","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1097\/JTO.0b013e3181e2f247","volume":"5","author":"R Maeda","year":"2010","unstructured":"Maeda R, Yoshida J, Ishii G, Aokage K, Hishida T, Nishimura M, Nishiwaki Y, Nagai K (2010) Long-term outcome and late recurrence in patients with completely resected stage IA non-small cell lung cancer. J Thorac Oncol 5:1246\u20131250","journal-title":"J Thorac Oncol"},{"key":"2858_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.lungcan.2013.06.021","volume":"82","author":"KM Monirul Islam","year":"2013","unstructured":"Monirul Islam KM, Shostrom V, Kessinger A, Ganti AK (2013) Outcomes following surgical treatment compared to radiation for stage I NSCLC: a SEER database analysis. Lung Cancer 82:90\u201394","journal-title":"Lung Cancer"},{"key":"2858_CR10","first-page":"784","volume":"45","author":"N Paquet","year":"2004","unstructured":"Paquet N, Albert A, Foidart J, Hustinx R (2004) Within-patient variability of (18)F-FDG: standardized uptake values in normal tissues. J Nucl Med 45:784\u2013788","journal-title":"J Nucl Med"},{"key":"2858_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2967\/jnumed.114.147561","volume":"56","author":"SY Park","year":"2015","unstructured":"Park SY, Cho A, Yu WS, Lee CY, Lee JG, Kim DJ, Chung KY (2015) Prognostic value of total lesion glycolysis by 18F-FDG PET\/CT in surgically resected stage IA non-small cell lung cancer. J Nucl Med 56:45\u201349","journal-title":"J Nucl Med"},{"key":"2858_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s13139-016-0456-3","volume":"51","author":"S Shin","year":"2017","unstructured":"Shin S, Pak K, Kim IJ, Kim BS, Kim SJ (2017) Prognostic value of tumor-to-blood standardized uptake ratio in patients with resectable non-small-cell lung cancer. Nucl Med Mol Imaging 51:233\u2013239","journal-title":"Nucl Med Mol Imaging"},{"key":"2858_CR13","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/ejcts\/ezt333","volume":"45","author":"IH Song","year":"2014","unstructured":"Song IH, Yeom SW, Heo S, Choi WS, Yang HC, Jheon S, Kim K, Cho S (2014) Prognostic factors for post-recurrence survival in patients with completely resected stage I non-small-cell lung cancer. Eur J Cardiothorac Surg 45:262\u2013267","journal-title":"Eur J Cardiothorac Surg"},{"key":"2858_CR14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/JTO.0b013e31818307a7","volume":"3","author":"H Vesselle","year":"2008","unstructured":"Vesselle H, Salskov A, Turcotte E, Wiens L, Schmidt R, Jordan CD, Vallieres E, Wood DE (2008) Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index. J Thorac Oncol 3:971\u2013978","journal-title":"J Thorac Oncol"},{"key":"2858_CR15","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1097\/MNM.0b013e32836491a9","volume":"34","author":"CC Vu","year":"2013","unstructured":"Vu CC, Matthews R, Kim B, Franceschi D, Bilfinger TV, Moore WH (2013) Prognostic value of metabolic tumor volume and total lesion glycolysis from 18F-FDG PET\/CT in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. Nucl Med Commun 34:959\u2013963","journal-title":"Nucl Med Commun"},{"key":"2858_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.acra.2012.07.002","volume":"20","author":"H Zhang","year":"2013","unstructured":"Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y (2013) Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Acad Radiol 20:32\u201340","journal-title":"Acad Radiol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-019-02858-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02858-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T19:07:55Z","timestamp":1581534475000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-019-02858-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["2858"],"URL":"https:\/\/doi.org\/10.1007\/s00432-019-02858-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,13]]},"assertion":[{"value":"19 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this retrospective study, formal consent is not required. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}]}}